A61K 31 - Medicinal preparations containing organic active ingredients

Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
10/2001
10/18/2001	WO2001076361A1 Animal and cell models for type ii diabetes and their use
10/18/2001	WO2001039724A3 Phosphonate compounds
10/18/2001	WO2001038316A3 Sulfonyl oxazole amines and their use as 5-ht6 receptor ligands
10/18/2001	WO2001036626A3 Pentraxin i and pentraxin receptor, inhibitors of said proteins and pharmaceutical compositions containing said compounds
10/18/2001	WO2001035933A3 A method of microencapsulation
10/18/2001	WO2001031015A3 36p6d5: secreted tumor antigen
10/18/2001	WO2001030342A9 Flavones as inducible nitric oxide synthase inhibitors, cyclooxygenase-2 inhibitors and potassium channel activators
10/18/2001	WO2001028337A3 Antiviral compositions for tissue paper
10/18/2001	WO2001026650A3 Use of n-acyl homoserine lactones for the treatment of cardiac tachyarrhythmias, ischaemic heart disease or congestive heart failure
10/18/2001	WO2001026640A3 Treatment of osteoporosis
10/18/2001	WO2001025213B1 Pyrrolo imidazole derivatives and their use as medicaments
10/18/2001	WO2001023540A3 P-glycoproteins and uses thereof
10/18/2001	WO2001023388A3 AMINO SUBSTITUTED PYRAZOLO[1,5,-a]-1,5-PYRIMIDINES AND PYRAZOLO[1,5-a]-1,3,5-TRIAZINES
10/18/2001	WO2001022090A9 Method for identifying compounds useful in the therapy of bone disorders
10/18/2001	WO2001020336A3 SCREENING FOR α2δ-1 SUBUNIT BINDING LIGANDS
10/18/2001	WO2000078299A3 Composition and method for preventing/reducing the severity of side effects of chemotherapy and/or radiation therapy
10/18/2001	WO2000071518A3 Heterocyclic analgesic compounds and their use
10/18/2001	WO2000064424A8 Cystic fibrosis medicaments
10/18/2001	WO2000057837A9 Compositions and methods for effecting the levels of cholesterol
10/18/2001	WO2000035436A3 Treatment of arthritis with mek inhibitors
10/18/2001	US20010031965 Spine distraction implant and method
10/18/2001	US20010031895 Intermediate p-cyclopropanoyl cumene compounds and derivatives, optionally having a 3-hydroxy group; 1-(benzoylalkyl)-4-(diphenylmethoxy)-piperidine compounds and 1-(a-hydroxybenzylalkyl)-4-(diphenylalkenyl)-piperidines
10/18/2001	US20010031882 Lipoxin compounds and their use in treating cell proliferative disorders
10/18/2001	US20010031878 Novel processes for making- and a new crystalline form of- leflunomide
10/18/2001	US20010031877 Eprosartan dihydate and a process for its production and formulation
10/18/2001	US20010031874 Thiourea and benzamide compounds, compositions and methods of treating or preventing inflammatory diseases and atherosclerosis
10/18/2001	US20010031870 Benzamide and sulfonamide substitued aminoguanidines and alkoxyguanidines as protese inhibitors
10/18/2001	US20010031868 By reaction of a 2,5-diamino-4,6-dihalopyrimidine with formic acid
10/18/2001	US20010031801 Pumping active agent, polymer, and solvent, form emulsion; forming an emulsion; solvent extraction;
10/18/2001	US20010031790 Reducing plasma levels of alpha -dicarbonyl compounds by administering excess metformin
10/18/2001	US20010031789 2-n-propyl-4-hexynoic acid; reduced adverse effects including neurotoxicity and teratogenic potential compared to valproic acid
10/18/2001	US20010031788 Anticancer agents, osteoporosis, arteriosclerosis, restnosis,vision defects
10/18/2001	US20010031787 Minimizing skin damage, irritation or sensitization; nontoxic; used in urogenital disorders
10/18/2001	US20010031785 Orally administering zinc tranexamate for diabetis therapy
10/18/2001	US20010031784 Antidepressants; simplification
10/18/2001	US20010031783 Alpha-pyrone compositions and method for the chemoprevention of cancer
10/18/2001	US20010031782 Use of gamma-tocopherol and its oxidative metabolite LLU-alpha in the treatment of disease
10/18/2001	US20010031780 Compounds such as (s,s)1-(2-amino-3,3-dimethyl-butyryl)-2,5-dihydro-1h-pyrrole-2 -carbonitrile administered as antidiabetic agents; dipeptidyl peptidase-iv (dpp-iv)
10/18/2001	US20010031779 Methods and materials for treating and preventing inflammation of mucosal tissue
10/18/2001	US20010031778 Triazole antifungal agent
10/18/2001	US20010031777 Heterocyclic compounds and their therapeutic use
10/18/2001	US20010031776 Use of thiazolidinediones for the treatment of hyperglycaemia
10/18/2001	US20010031773 Administering (5-aryl-1,2,4-thiadiazol)-3-yl thiourea and urea derivatives to treat hepatitis, HIV and Kaposi sarcoma, as viricides and anticarcinogenic agents
10/18/2001	US20010031772 Substituted 3-phenyl-5-alkoxy-1,3,4-oxadiazol-2-ones, their preparation and their use as pharmaceuticals
10/18/2001	US20010031770 Pyridoxal analogues and methods of treatment
10/18/2001	US20010031769 Pharmaceutical compositions
10/18/2001	US20010031768 Triazole antifungal agent
10/18/2001	US20010031767 Used as antidepressants, to treat obsessive compulsive disorder, panic disorders, bulimia, anorexia, pain, obesity, senile demential, migraines, and social phobias
10/18/2001	US20010031766 Prostaglandin receptor ligands
10/18/2001	US20010031765 Antiviral compounds
10/18/2001	US20010031763 Substituted bis-acridines and related compounds as CCR5 receptor ligands, anti-inflammatory agents and anti-viral agents
10/18/2001	US20010031761 Compounds such as camptothecin 20-o-nonanoate; antitumor agents; low toxicity; good absorbability
10/18/2001	US20010031760 Method of treating a patient having precancerous lesions with quinazoline derivatives
10/18/2001	US20010031757 Administering compounds such as 3-(2-phenylethylamino)-6-methyl-1-(2-amino-6-methyl-5-methylene -carboxamidomethylpyridi nyl)-2-pyrazinone, N'-((1-(Aminoiminomethyl)4-piperidinyl) methyl)-N-(3,3- diphenylpropionyl)-L-proline amide
10/18/2001	US20010031756 Inclusion complexes of aryl-heterocyclic salts
10/18/2001	US20010031755 Novel compositions comprising trimetrexate
10/18/2001	US20010031754 Method for treating ocular pain
10/18/2001	US20010031752 Administered as anorexigenic agents, dietetics, antidiabetics and for enhancing lipid metabolism
10/18/2001	US20010031750 Administering an analgesic of an inhibitor of cyclic guanosine monophosphate dependent protein kinase such as rp-8-((4-chlorophenyl)thio)-guanosine 3',5'-cyclic monophosphothioate triethylamine
10/18/2001	US20010031749 Antibiotic
10/18/2001	US20010031748 Use of metal complexes to treat gastrointestinal infections
10/18/2001	US20010031747 Progestin therapy for maintaining amenorrhea
10/18/2001	US20010031746 Nervous system disorders; psychological disorders
10/18/2001	US20010031745 Antiviral purine derivatives
10/18/2001	US20010031744 Using mixture of plant extract and angiogenesis inhibitor
10/18/2001	US20010031743 Vision defects
10/18/2001	US20010031742 Pharmaceutical use of adenosine agonists
10/18/2001	US20010031741 Methods for treatment of lysosomal storage diseases
10/18/2001	US20010031736 Adduct of antibiotic and mucolytic agent
10/18/2001	US20010031735 Flavonoide esters and their use notably in cosmetics
10/18/2001	US20010031731 Free radical scavengers or promoters thereof as therapeutic adjuvants in preterm parturition
10/18/2001	US20010031730 Method for treatment of glutamate related disorders
10/18/2001	US20010031722 Methods and reagents for facilitating transcription
10/18/2001	US20010031721 Mixture with arginine; storage stability
10/18/2001	US20010031497 Complex of chitosan-based compound and a nucleic acid or oligonucleotide; delivers oligonucleotide into cell; non-viral gene delivery
10/18/2001	US20010031460 To prevent restenosis; drug screening by assaying a compound for activity as an alpha 1a-adrenergic receptor (alpha1A-AR) or alpha 1a/alpha 1d-AR selective antagonist
10/18/2001	US20010031285 Interleukin-4 production inhibitors
10/18/2001	US20010031282 Dissolving solid in dimethyl ether under pressure; precipitation; separation
10/18/2001	US20010031281 Compositon to enhance permeation of topical skin agents
10/18/2001	US20010031279 Phenoxyethyl substituted 1,2,4-triazolone
10/18/2001	US20010031278 Bioavailability; mixture with carrier
10/18/2001	US20010031275 Sesamol inhibitor of delta-5-desaturase activity and uses therefor
10/18/2001	US20010031250 Treating hair by targeting enzymes
10/18/2001	US20010031249 Composition for inhibiting body odor and uses thereof
10/18/2001	US20010031246 Oral composition
10/18/2001	US20010029959 Nicotine salts having improved taste, process for their preparation and their use
10/18/2001	DE10108042A1 Crystalline citalopram base and salts with high purity useful for treatment of depression
10/18/2001	DE10019171A1 Zusammensetzungen zur Verwendung als Penetrationsverstärker in transdermalen Formulierungen für hoch lipophile Wirkstoffe Compositions for use as penetration enhancers in transdermal formulations for highly lipophilic substances
10/18/2001	DE10019167A1 New 8 beta-substituted 11 beta-(pentyl or hexyl)-estra-1,3,5(10)-triene derivatives, are ovary-selective estrogen receptor ligands useful e.g. as female or male contraceptives or for treating ovarian carcinoma
10/18/2001	DE10019076A1 Verwendung von Polygalakturoniden als Lebensmittelzusatzstoffe Use of polygalacturonides as food additives
10/18/2001	DE10018370A1 Synergistic pesticidal composition containing phenyl-substituted furanone compound and e.g. chlorfluazuron, emamectin, endosulfan, fibronil or azadirachtin, especially useful as insecticide or acaricide
10/18/2001	DE10017996A1 New terbinafine tablets and a regimen for the treatment of onychomycosis
10/18/2001	DE10016559A1 System für den Transport von Aktivstoffen in einem biologischen System System for transporting active substances in a biological system
10/18/2001	DE10014127A1 Antibacterial, fungicidal, antiviral, antiparasitic and herbicidal agents for medicinal, veterinary or agricultural use, comprising amino- or imino-substituted organophosphorus compounds having nitrogen-containing spacer group
10/18/2001	DE10013782A1 4-Fluoralkyl-2H-benzopyrane mit antiestrogener Wirksamkeit, Verfahren zu ihrer Herstellung, pharmazeutische Präparate, die diese enthalten sowie deren Verwendung zur Herstellung von Arzneimitteln 4-fluoroalkyl-2H-benzopyrans with antiestrogenic action, processes for their preparation, pharmaceutical compositions containing them and their use for the preparation of medicaments
10/18/2001	DE10013539A1 Lipopolysaccharide aus Escherichia coli Lipopolysaccharides from Escherichia coli
10/18/2001	DE10007234A1 Peptid und dafür kodierende Nukleinsäure zur Bestimmung, Diagnostik und Therapie von Erkrankungen des Nervensystems Peptide and nucleic acid coding for determining diagnosis and treatment of diseases of the nervous system
10/18/2001	CA2414652A1 Animal and cell models for type ii diabetes and their use
10/18/2001	CA2409782A1 Drug delivery composition and device
10/18/2001	CA2406485A1 Hpv-specific short-mers

1 ... 5988 5989 5990 5991 5992 5993 5994 5995 5996 5997 5998 5999 6000 6001 6002 6003 6004 6005 6006 6007 6008 ... 7860